reports
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights D...
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer PRINCETON, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, today announced the publication of a comprehensive review of the clinical development program for ZUSDURI™ (mitomycin) for intravesical solution, formerly known as UGN-102, the first and only FDA-a...
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 56...
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 40 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of Jelmyto® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical ...
UroGen Pharma to Present at Upcoming Investor Conferences
UroGen Pharma to Present at Upcoming Investor Conferences PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in September. Wells Fargo Healthcare Conference Date / Time:September 3rd, at 2:15 PM ETFormat:Fireside ChatLocation:Boston, MA Cantor Fitzgerald Global Healthcare Conference Date / Time:September 4th, at 3:55 PM ETFormat:Fireside ChatLocati...
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and...
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results ZUSDURI™ (mitomycin) for intravesical solution now available as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC)JELMYTO® achieved net product sales of $24.2 million in Q2 2025, compared with $21.8 million in Q2 2024, representing 11% year-over-year growth$161.6 million in cash, cash equivalents and marketable securities as of June 30, 2025 Conference call and webcast to be held to...
UroGen Announces 24-Month Duration of Response of 72.2% from the Pivot...
UroGen Announces 24-Month Duration of Response of 72.2% from the Pivotal Phase 3 ENVISION Trial of ZUSDURI, the First and Only FDA-Approved Medicine for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer 24-month Duration of Response (DOR) of 72.2% by Kaplan-Meier estimate was attained in patients who achieved a complete response (CR) at three months (79.6%) PRINCETON, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cance...
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thurs...
UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025 Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report second quarter 2025 financial results on Thursday, August 7th, 2025, prior to the open of the stock market. The announcement will be followed by a live audio webcast a...
UroGen Announces Publication of Phase 3b Study Results Demonstrating t...
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty cancers, today announced the publication in Reviews in Urology of results from a Phase 3b study evaluating the feasibility of administering ZUSDURI™ (mitomycin) for intravesical s...
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II ...
UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical solution. Among the 17 patients who achieved complete response and entered a long-term extension study, the median duration of response was 3.5 years by Kaplan-Meier estimate. PRINCET...
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinic...
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed patient enrollment in its Phase 3 UTOPIA clinical trial of UGN-103 (mitomycin) for intravesical solution, a next-generation formulation in development for the ...
UroGen Pharma Announces Commencement of Public Offering of Ordinary Sh...
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants. In connection with the proposed offering, UroGen also expects to grant the underwriters a 30-day option to p...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ROL ROLLINS INC.
PSIX POWER SOLUTIONS INTERNATIONAL INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
LMAT LEMAITRE VASCULAR INC.
IRT INDEPENDENCE REALTY TRUST INC.
HAS HASBRO INC.
ESS ESSEX PROPERTY TRUST INC.
CDNS CADENCE DESIGN SYSTEMS INC.
ADBE ADOBE INC.
NFLX NETFLIX INC.
TTC TORO COMPANY
USM UNITED STATES CELLULAR CORP
USLM U.S. LIME & MINERALS
URGN UROGEN PHARMA
AVGO BROADCOM INC.
SPOT SPOTIFY TECHNOLOGY SA
FRHC FREEDOM HOLDING CORP
DCTH DELCATH SYSTEMS
TERN TERNS PHARMACEUTICALS
SMMT SUMMIT THERAPEUTICS INC
MEG MONTROSE ENVIRONMENTAL GROUP
ALHC ALIGNMENT HEALTHCARE INC
MITT AG MORTGAGE INVESTMENT TRUST INC
APP APPLOVIN CORP
ASTS AST SPACEMOBILE INC
NU NU HLDGS LTD
BRCC BRC INC
NGNE NEUROGENE INC
AKA AKA BRANDS HOLDING CORP
INST INSTRUCTURE HLDGS INC
SYRS SYROS PHARMACEUTICALS INC.
AUID AUTHID INC
NLCP NEWLAKE CAPITAL PARTNERS INC COM
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
WLDN WILLDAN GROUP
TDS TELEPHONE AND DATA SYSTEMS INC.
OSUR ORASURE TECHNOLOGIES INC.
ICFI ICF INTERNATIONAL INC.
BGS B&G FOODS INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
QUAD QUAD/GRAPHICS INC. CLASS A
GTN GRAY TELEVISION INC.
USM UNITED STATES CELLULAR CORP
INFU INFUSYSTEMS HOLDINGS INC.
IRTC IRHYTHM TECHNOLOGIES INC.
URGN UROGEN PHARMA
DESP DESPEGAR.COM CORP.
BKNG BOOKING HOLDINGS INC.
ALEC ALECTOR
PGNY PROGYNY
ACEL ACCEL ENTERTAINMENT (A)
PRDO PERDOCEO EDUCATION CORP
LSEA LANDSEA HOMES CORP (A)
DFH DREAM FINDERS HOMES
PHVS PHARVARIS NV
DKNG AMGEN INC
GLSI DRAFTKINGS INC.
GREENWICH LIFESCIENCES INC
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
BAH, HURN, NOTV, PAGS, SPOK, ROKU, BZH, HOV, MTH, SKX, SAM, DESP, BJRI, RKLB, IONQ, KLAC, INTC, CNX, CLB, CRK, OVV, SOFI, TROW, AX, CINF, DLR, ABR, RWT, BFST, INBK, AUPH, BBIO, DSGN, RPHM, URGN, RCEL, AXNX, CUTR, PLSE, In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patte...
MTH MERITAGE HOMES CORPORATION
HURN HURON CONSULTING GROUP INC.
CUTR CUTERA INC.
BZH BEAZER HOMES USA INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
BJRI BJ'S RESTAURANTS INC.
AUP AURINIA PHARMACEUTICALS INC.
SAM BOSTON BEER COMPANY INC. CLASS A
SPOK SPOK HOLDINGS
PLSE PULSE BIOSCIENCES
URGN UROGEN PHARMA
ROKU ROKU INC. CLASS A
DESP DESPEGAR.COM CORP.
PAGS PAGSEGURO DIGITAL LTD
HOV HOVNANIAN ENTERPRISES INC. CLASS A
BBIO BRIDGEBIO PHARMA
NOTV INOTIV INC
DSGN DESIGN THERAPEUTICS INC
RPHM RENEO PHARMACEUTICALS INC
RKLB ROCKET LAB USA INC
RCEL AVITA MEDICAL INC
AKNX TEKHNOLOGII 100
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
EME EMCOR GROUP
CMCSA COMCAST CORPORATION CLASS A
LII LENNOX INTERNATIONAL INC.
WDC WESTERN DIGITAL CORPORATION
VNO VORNADO REALTY TRUST
TXT TEXTRON INC.
PNR PENTAIR PLC
ORRF ORRSTOWN FINANCIAL SERVICES INC.
ON ON SEMICONDUCTOR CORPORATION
NYCB NEW YORK COMMUNITY BANCORP INC.
FORM FORMFACTOR INC.
CRS CARPENTER TECHNOLOGY CORPORATION
AR ANTERO RESOURCES CORPORATION
AMSC AMERICAN SUPERCONDUCTOR CORP.
AEIS ADVANCED ENERGY INDUSTRIES INC.
QUAD QUAD/GRAPHICS INC. CLASS A
JOE ST. JOE COMPANY
CCL CARNIVAL CORPORATION
HLX HELIX ENERGY SOLUTIONS GROUP INC.
HP HELMERICH & PAYNE INC.
VSTO VISTA OUTDOOR INC
BF.A BROWN-FORMAN CORP. CL A
ITGR INTEGER HOLDINGS CORPORATION
USAP UNIVERSAL STAINLESS & ALLOY PRODUCTS INC.
URGN UROGEN PHARMA
EOLS EVOLUS INC
CMPR CIMPRESS PLC
CARR CARRIER GLOBAL CORP.
TARS TARSUS PHARMACEUTICALS
OS OFFICINA STELLARE
TCBX THIRD COAST BANCSHARES INC
FAF FIRE & FLOWERS HLDGS CORP
N INCO LTD.
- Jonathan Moreland
HZN HORIZON GLOBAL CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
CUTR CUTERA INC.
NCBS NICOLET BANKSHARES INC
NAUT NAUTILUS MARINE SERVICES
KBR KBR INC.
IROQ IF BANCORP INC
CTHR CHARLES & COLVARD LTD.
MRSN MERSANA THERAPEUTICS
URGN UROGEN PHARMA
PETQ PETIQ INC. CLASS A
FRPT FORCE PROTECTION
BHC INC.
ELAN BAUSCH HEALTH COMPANIES INC.
KFS ELANCO ANIMAL HEALTH INC.
OTLK KINGSWAY FINANCIAL SERVICES
BRBR OUTLOOK THERAPEUTICS
AHCO BELLRING BRANDS
AESE ADAPTHEALTH
RC ALLIED ESPORTS ENTERTAINMENT
HGBL GRUPO RADIO CENTRO S.A.B. DE C.V.
PSTX HERITAGE GLOBAL
HPK POSEIDA THERAPEUTICS
OLMA INC.
OEG HIGHPEAK ENERGY INC (A)
BVH OLEMA PHARMACEUTICALS
FLUX ORBITAL ENERGY GROUP
TPGY BLUEGREEN VACATIONS HOLDING CORPORATION (A)
CYTH FLUX POWER HOLDINGS
CNTA TPG PACE BENEFICIAL FINANCE
NSPR CYCLO THERAPEUTICS
STGW CENTESSA PHARMACEUTICALS PLC
INSPIREMD INC
STAGWELL INC
Urogen Pharma Ltd: 2 directors
Two Directors at Urogen Pharma Ltd bought/maiden bought 5,000 shares at between 15.710USD and 15.850USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
- Dave Nicoski
- Ross LaDuke
TXMD THERAPEUTICSMD INC.
TSN TYSON FOODS INC. CLASS A
PPC PILGRIM'S PRIDE CORPORATION
PBYI PUMA BIOTECHNOLOGY INC.
LOPE GRAND CANYON EDUCATION INC.
HBI HANESBRANDS INC.
GD GENERAL DYNAMICS CORPORATION
FARM FARMER BROS. CO.
ENTA ENANTA PHARMACEUTICALS INC.
CLVS CLOVIS ONCOLOGY INC.
CLR CONTINENTAL RESOURCES INC.
ASC ARDMORE SHIPPING
ACRX ACELRX PHARMACEUTICALS
ABEO ABEONA THERAPEUTICS INC.
QUAD QUAD/GRAPHICS INC. CLASS A
HFC HOLLYFRONTIER CORPORATION
KEX KIRBY CORPORATION
TRC TEJON RANCH CO.
JBSS JOHN B. SANFILIPPO & SON INC.
INGR-R-A INGRA D.D.
URGN UROGEN PHARMA
TYME TYME TECHNOLOGIES
XFOR X4 PHARMACEUTICALS INC
APLT APPLIED THERAPEUTICS
TH TARGET HOSPITALITY CORP (A)
OYST OYSTER POINT PHARMA
SOLY SOLITON INC
RTX RAYTHEON TECHNOLOGIES CORPORATION
DSS DOCUMENT SECURITY SYSTEMS
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
XONE EXONE CO
VKTX VIKING THERAPEUTICS
VIVO MERIDIAN BIOSCIENCE INC.
SMED SHARPS COMPLIANCE
SM SM ENERGY COMPANY
QADA QAD CLASS A
PERI PERION NETWORK LTD
ENLV ENLIVEX THERAPEUTICS
NK NANTKWEST
KRNT KORNIT DIGITAL LTD.
ICAD ICAD INC.
FCX FREEPORT-MCMORAN INC.
DRNA DICERNA PHARMACEUTICALS
DDD 3D SYSTEMS CORPORATION
CPST CAPSTONE TURBINE CORP.
CLVS CLOVIS ONCOLOGY INC.
ARWR ARROWHEAD PHARMACEUTICALS INC.
APPS DIGITAL TURBINE
ATKR ATKORE INC
ZIXI ZIX CORP.
MSON MISONIX INC.
AP AMPCO-PITTSBURGH
PLSE PULSE BIOSCIENCES
FLGT FULGENT GENETICS
PUMP PROPETRO HOLDING CORP.
VREX VAREX IMAGING CORPORATION
EXPI EXP WORLD HOLDINGS
URGN UROGEN PHARMA
RFL RAFAEL HOLDINGS CL B
FLNT FLUENT INC
STIM NEURONETICS
INS INSTONE REAL ESTATE GROUP AG
TBIO TRANSLATE BIO
ORGO ORGANOGENESIS HOLDINGS (A)
DT DYNATRACE INC.
AXLA AXCELLA HEALTH
SWTX SPRINGWORKS THERAPEUTICS
OCGN OCUGEN INC
XGN EXAGEN
DMTK DERMTECH INC
RVMD REVOLUTION MEDICINES
VRM VROOM
CPE CALLON PETROLEUM
BILL BILL.COM HOLDINGS
BEAM BEAM THERAPEUTICS
AMTI APPLIED MOLECULAR TRANSPORT
DNMR DANIMER SCIENTIFIC
PUBM INC.
RUBY PUBMATIC
RBC U.S. BANKS YIELD INDEX ETF
- Dave Nicoski
- Ross LaDuke
OXY OCCIDENTAL PETROLEUM CORPORATION
USB U.S. BANCORP
C CITIGROUP INC.
SRDX SURMODICS INC.
RYAM RAYONIER ADVANCED MATERIALS INC
NVTA INVITAE CORP
NUS NU SKIN ENTERPRISES INC. CLASS A
NKTR NEKTAR THERAPEUTICS
GPS GAP INC.
GDOT GREEN DOT CORPORATION CLASS A
FPRX FIVE PRIME THERAPEUTICS INC.
FOXF FOX FACTORY HOLDING CORP.
FITB FIFTH THIRD BANCORP
FCX FREEPORT-MCMORAN INC.
EZPW EZCORP INC. CLASS A
EIGI ENDURANCE INTERNATIONAL GROUP HOLDINGS INC.
EDIT EDITAS MEDICINE INC.
DY DYCOM INDUSTRIES INC.
DVAX DYNAVAX TECHNOLOGIES CORPORATION
CFG CITIZENS FINANCIAL GROUP INC.
BOX BOX INC. CLASS A
AMG AFFILIATED MANAGERS GROUP INC.
AGIO AGIOS PHARMACEUTICALS INC.
AFMD AFFIMED N.V.
AEO AMERICAN EAGLE OUTFITTERS INC.
AAP ADVANCE AUTO PARTS INC.
FLR FLUOR CORPORATION
ARCB ARCBEST CORPORATION
ATRO ASTRONICS CORPORATION
CENX CENTURY ALUMINUM COMPANY
FSLR FIRST SOLAR INC.
GIII G-III APPAREL GROUP LTD.
MPX MARINE PRODUCTS CORP.
SCVL SHOE CARNIVAL INC.
CC CHEMOURS CO.
FBK FB FINANCIAL CORPORATION
AA ALCOA CORPORATION
HOME AT HOME GROUP INC.
ANAB ANAPTYSBIO INC.
URGN UROGEN PHARMA
CATC CAMBRIDGE BANCORP
OPTN OPTINOSE
DSKE DASEKE
UBX UNITY BIOTECHNOLOGY
FOCS FOCUS FINANCIAL PARTNERS
UPWK UPWORK
CYCN CYCLERION THERAPEUTICS
DELL DELL TECHNOLOGIES INC CLASS C
HCAT HEALTH CATALYST
REZI RESIDEO TECHNOLOGIES INC.
CRMD CORMEDIX INC.
- Jonathan Moreland
LNG CHENIERE ENERGY INC.
VVI VIAD CORP
VIVO MERIDIAN BIOSCIENCE INC.
TNAV TELENAV
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
RYAM RAYONIER ADVANCED MATERIALS INC
PRTY PARTY CITY HOLDCO INC.
PFLT PENNANTPARK FLOATING RATE CAPITAL LTD.
OPK OPKO HEALTH INC.
NGL NGL ENERGY PARTNERS LP
MTDR MATADOR RESOURCES COMPANY
MCD MCDONALD'S CORPORATION
JRVR JAMES RIVER GROUP HOLDINGS LTD
GVA GRANITE CONSTRUCTION INCORPORATED
ESPR ESPERION THERAPEUTICS INC.
AKBA AKEBIA THERAPEUTICS INC.
AGIO AGIOS PHARMACEUTICALS INC.
UVE UNIVERSAL INSURANCE HOLDINGS INC.
MTNB MATINAS BIOPHARMA HOLDINGS INC
SAFE SAFESTORE HOLDINGS PLC
CNFR CONIFER HOLDINGS
ET ENERGY TRANSFER L.P.
FET FORUM ENERGY TECHNOLOGIES INC.
PAGP PLAINS GP HOLDINGS LP CLASS A
TDC TERADATA CORPORATION
FLXS FLEXSTEEL INDUSTRIES INC.
BXC BLUELINX HOLDINGS
NBLX NOBLE MIDSTREAM PARTNERS LP
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
XM91 SMTC CORP.
URGN UROGEN PHARMA
ANGI ANGI INC. CLASS A
TURN 180 DEGREE CAPITAL
HOG HARLEY-DAVIDSON INC.
STKL SUNOPTA
SMPL INC.
MVBF SIMPLY GOOD FOODS CO
PED MVB FINANCIAL CORP
TORC PEDEVCO CORP
CLNC RESTORBIO INC
AMEH COLONY CREDIT REAL ESTATE (A)
ZVO APOLLO MEDICAL HOLDINGS INC
MEC ZOVIO INC
APRN MAYVILLE ENGINEERING
WORK BLUE APRON HOLDINGS
CTVA SLACK TECHNOLOGIES
ANDE INC.
GCI CORTEVA
OXLC INC.
THE ANDERSONS
INC.
GANNETT CO. INC.
OXFORD LANE CAPITAL CORP.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.